Both GG 5 and a detectable nadir PSA were significant risk factors for prostate cancer death in N1M0 patients; therefore, we may need to study the effects of increasing the intensity of treatment for such cases prior to CRPC progression. This evidence concerns the gene KLK3 and prostate carcinoma.